Literature DB >> 33428651

Robust radiogenomics approach to the identification of EGFR mutations among patients with NSCLC from three different countries using topologically invariant Betti numbers.

Kenta Ninomiya1, Hidetaka Arimura2, Wai Yee Chan3, Kentaro Tanaka4, Shinichi Mizuno5, Nadia Fareeda Muhammad Gowdh3, Nur Adura Yaakup3, Chong-Kin Liam6, Chee-Shee Chai7, Kwan Hoong Ng3.   

Abstract

OBJECTIVES: To propose a novel robust radiogenomics approach to the identification of epidermal growth factor receptor (EGFR) mutations among patients with non-small cell lung cancer (NSCLC) using Betti numbers (BNs).
MATERIALS AND METHODS: Contrast enhanced computed tomography (CT) images of 194 multi-racial NSCLC patients (79 EGFR mutants and 115 wildtypes) were collected from three different countries using 5 manufacturers' scanners with a variety of scanning parameters. Ninety-nine cases obtained from the University of Malaya Medical Centre (UMMC) in Malaysia were used for training and validation procedures. Forty-one cases collected from the Kyushu University Hospital (KUH) in Japan and fifty-four cases obtained from The Cancer Imaging Archive (TCIA) in America were used for a test procedure. Radiomic features were obtained from BN maps, which represent topologically invariant heterogeneous characteristics of lung cancer on CT images, by applying histogram- and texture-based feature computations. A BN-based signature was determined using support vector machine (SVM) models with the best combination of features that maximized a robustness index (RI) which defined a higher total area under receiver operating characteristics curves (AUCs) and lower difference of AUCs between the training and the validation. The SVM model was built using the signature and optimized in a five-fold cross validation. The BN-based model was compared to conventional original image (OI)- and wavelet-decomposition (WD)-based models with respect to the RI between the validation and the test.
RESULTS: The BN-based model showed a higher RI of 1.51 compared with the models based on the OI (RI: 1.33) and the WD (RI: 1.29).
CONCLUSION: The proposed model showed higher robustness than the conventional models in the identification of EGFR mutations among NSCLC patients. The results suggested the robustness of the BN-based approach against variations in image scanner/scanning parameters.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33428651      PMCID: PMC7799813          DOI: 10.1371/journal.pone.0244354

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  40 in total

1.  Guidelines for radiologically guided lung biopsy.

Authors:  A Manhire; M Charig; C Clelland; F Gleeson; R Miller; H Moss; K Pointon; C Richardson; E Sawicka
Journal:  Thorax       Date:  2003-11       Impact factor: 9.139

2.  Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.

Authors:  Xinguan Yang; Xiao Dong; Jiao Wang; Weiwei Li; Zhuoran Gu; Dashan Gao; Nanshan Zhong; Yubao Guan
Journal:  Oncologist       Date:  2019-04-01

3.  EGFR testing in lung cancer is ready for prime time.

Authors:  Fred R Hirsch; Paul A Bunn
Journal:  Lancet Oncol       Date:  2009-05       Impact factor: 41.316

4.  Identification of optimal mother wavelets in survival prediction of lung cancer patients using wavelet decomposition-based radiomic features.

Authors:  Mazen Soufi; Hidetaka Arimura; Noriyuki Nagami
Journal:  Med Phys       Date:  2018-10-19       Impact factor: 4.071

5.  Uncertainty analysis of quantitative imaging features extracted from contrast-enhanced CT in lung tumors.

Authors:  Jinzhong Yang; Lifei Zhang; Xenia J Fave; David V Fried; Francesco C Stingo; Chaan S Ng; Laurence E Court
Journal:  Comput Med Imaging Graph       Date:  2015-12-14       Impact factor: 4.790

6.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

Authors:  Peter Goldstraw; Kari Chansky; John Crowley; Ramon Rami-Porta; Hisao Asamura; Wilfried E E Eberhardt; Andrew G Nicholson; Patti Groome; Alan Mitchell; Vanessa Bolejack
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609

7.  Homology-based method for detecting regions of interest in colonic digital images.

Authors:  Kazuaki Nakane; Akihiro Takiyama; Seiji Mori; Nariaki Matsuura
Journal:  Diagn Pathol       Date:  2015-04-24       Impact factor: 2.644

8.  Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning.

Authors:  Shuo Wang; Jingyun Shi; Zhaoxiang Ye; Di Dong; Dongdong Yu; Mu Zhou; Ying Liu; Olivier Gevaert; Kun Wang; Yongbei Zhu; Hongyu Zhou; Zhenyu Liu; Jie Tian
Journal:  Eur Respir J       Date:  2019-03-28       Impact factor: 16.671

9.  Hepatic tumor classification using texture and topology analysis of non-contrast-enhanced three-dimensional T1-weighted MR images with a radiomics approach.

Authors:  Asuka Oyama; Yasuaki Hiraoka; Ippei Obayashi; Yusuke Saikawa; Shigeru Furui; Kenshiro Shiraishi; Shinobu Kumagai; Tatsuya Hayashi; Jun'ichi Kotoku
Journal:  Sci Rep       Date:  2019-06-19       Impact factor: 4.379

10.  Estimation of lung cancer risk using homology-based emphysema quantification in patients with lung nodules.

Authors:  Mizuho Nishio; Takeshi Kubo; Kaori Togashi
Journal:  PLoS One       Date:  2019-01-22       Impact factor: 3.240

View more
  4 in total

1.  Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.

Authors:  Meilinuer Abdurixiti; Mayila Nijiati; Rongfang Shen; Qiu Ya; Naibijiang Abuduxiku; Mayidili Nijiati
Journal:  Br J Radiol       Date:  2021-05-12       Impact factor: 3.629

Review 2.  Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.

Authors:  Cyra Y Kang; Samantha E Duarte; Hye Sung Kim; Eugene Kim; Jonghanne Park; Alice Daeun Lee; Yeseul Kim; Leeseul Kim; Sukjoo Cho; Yoojin Oh; Gahyun Gim; Inae Park; Dongyup Lee; Mohamed Abazeed; Yury S Velichko; Young Kwang Chae
Journal:  Oncologist       Date:  2022-06-08       Impact factor: 5.837

3.  Relapse predictability of topological signature on pretreatment planning CT images of stage I non-small cell lung cancer patients before treatment with stereotactic ablative radiotherapy.

Authors:  Takumi Kodama; Hidetaka Arimura; Yuko Shirakawa; Kenta Ninomiya; Tadamasa Yoshitake; Yoshiyuki Shioyama
Journal:  Thorac Cancer       Date:  2022-06-16       Impact factor: 3.223

4.  Synergistic combination of a topologically invariant imaging signature and a biomarker for the accurate prediction of symptomatic radiation pneumonitis before stereotactic ablative radiotherapy for lung cancer: A retrospective analysis.

Authors:  Kenta Ninomiya; Hidetaka Arimura; Tadamasa Yoshitake; Taka-Aki Hirose; Yoshiyuki Shioyama
Journal:  PLoS One       Date:  2022-01-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.